Europe Tests Japanese Drug for Hanta Virus

The European Union has dispatched shipments of an experimental anti-Hanta virus drug to France, Spain, and the Netherlands, aimed at containing the spread of the disease and treating cases. A total of 1,400 tablets of Favipiravir have been provided through a donation from the Japanese company Fujifilm. This medication is currently one of the main options available, given the lack of an approved treatment or vaccine for the Hanta virus. The use of the drug depends on the assessment of individual health conditions and national needs in each country.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل